These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 20590598)
1. Being mindful of seven-transmembrane receptor 'guests' when assessing agonist selectivity. Kenakin T Br J Pharmacol; 2010 Jul; 160(5):1045-7. PubMed ID: 20590598 [TBL] [Abstract][Full Text] [Related]
2. Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data. Stott LA; Hall DA; Holliday ND Biochem Pharmacol; 2016 Feb; 101():1-12. PubMed ID: 26478533 [TBL] [Abstract][Full Text] [Related]
3. A Complementary Scale of Biased Agonism for Agonists with Differing Maximal Responses. Burgueño J; Pujol M; Monroy X; Roche D; Varela MJ; Merlos M; Giraldo J Sci Rep; 2017 Nov; 7(1):15389. PubMed ID: 29133887 [TBL] [Abstract][Full Text] [Related]
4. Testing for inverse agonism with constitutive receptor systems. Kenakin T Curr Protoc Pharmacol; 2006 Apr; Chapter 9():Unit9.5. PubMed ID: 22294179 [TBL] [Abstract][Full Text] [Related]
6. Determination of adenosine A1 receptor agonist and antagonist pharmacology using Saccharomyces cerevisiae: implications for ligand screening and functional selectivity. Stewart GD; Valant C; Dowell SJ; Mijaljica D; Devenish RJ; Scammells PJ; Sexton PM; Christopoulos A J Pharmacol Exp Ther; 2009 Oct; 331(1):277-86. PubMed ID: 19641164 [TBL] [Abstract][Full Text] [Related]
7. Agonist binding, agonist affinity and agonist efficacy at G protein-coupled receptors. Strange PG Br J Pharmacol; 2008 Apr; 153(7):1353-63. PubMed ID: 18223670 [TBL] [Abstract][Full Text] [Related]
8. Delineating biased ligand efficacy at 7TM receptors from an experimental perspective. Galandrin S; Onfroy L; Poirot MC; Sénard JM; Galés C Int J Biochem Cell Biol; 2016 Aug; 77(Pt B):251-63. PubMed ID: 27107932 [TBL] [Abstract][Full Text] [Related]
9. The effect of assay formats on the estimation of melanocortin agonist affinity and efficacy using the operation model of agonism. Simon S; Young TJ; Nickolls SA Eur J Pharmacol; 2009 Aug; 615(1-3):33-9. PubMed ID: 19446549 [TBL] [Abstract][Full Text] [Related]
10. Estimation of the receptor-state affinity constants of ligands in functional studies using wild type and constitutively active mutant receptors: Implications for estimation of agonist bias. Ehlert FJ; Stein RS J Pharmacol Toxicol Methods; 2017; 83():94-106. PubMed ID: 27725245 [TBL] [Abstract][Full Text] [Related]
11. Quantitating Ligand Bias Using the Competitive Model of Ligand Activity. Stahl EL; Ehlert FJ; Bohn LM Methods Mol Biol; 2019; 1957():235-247. PubMed ID: 30919358 [TBL] [Abstract][Full Text] [Related]
12. The operational model of allosteric modulation of pharmacological agonism. Jakubík J; Randáková A; Chetverikov N; El-Fakahany EE; Doležal V Sci Rep; 2020 Sep; 10(1):14421. PubMed ID: 32879329 [TBL] [Abstract][Full Text] [Related]